中国乳业 ›› 2026, Vol. 0 ›› Issue (1): 58-64.doi: 10.12377/1671-4393.26.01.09

• 疾病防治 • 上一篇    下一篇

白头翁皂苷注射液对临床型奶牛乳房炎治疗效果的研究

杨胜男1, 李彦1, 张严琦1, 李国华1, 孙荣钊2, 刘欣3, 段笑笑1,*   

  1. 1.山东省青岛市动物疫病预防控制中心,山东青岛 266000;
    2.青岛立见生物科技有限公司 ,山东青岛 266041;
    3.河北远征药业有限公司,河北石家庄 050041
  • 出版日期:2026-01-25 发布日期:2026-03-09
  • 通讯作者: *段笑笑(1989-),女,河南济源人,硕士,高级兽医师,研究方向为疫病监测、流行病学调查等。
  • 作者简介:杨胜男(1987-),女,山东济南人,硕士,高级兽医师,研究方向为动物疫病防控;李 彦(1967-),男,山东青岛人,博士,研究员,研究方向为兽医药理学、动物疫病防控;张严琦(1986-),女,山东青岛人,硕士,高级兽医师,研究方向为动物疫病监测;李国华(1995-),男,山东济南人,本科,助理兽医师,研究方向为动物疫病监测;孙荣钊(1987-),男,山东即墨人,博士,高级兽医师,研究方向为动物疫病防控与检测;刘 欣(1976-),女,河北石家庄人,硕士,高级兽医师,研究方向为新兽药制剂开发。
  • 基金资助:
    青岛市科技惠民示范专项(25-1-5-xdny-30-nsh)

Research on the Therapeutic Effect of Pulsatilla Saponin Injection on Clinical Bovine Mastitis

YANG Shengnan1, LI Yan1, ZHANG Yanqi1, LI Guohua1, SUN Rongzhao2, LIU Xin3, DUAN Xiaoxiao1,*   

  1. 1. Qingdao Center For Animal Disease Control and Prevention, Shandong Province, Qingdao Shandong 266000;
    2. Qingdao Lijian Biotechnology Co., Ltd., Qingdao Shandong 266041;
    3. Hebei Yuanzheng Pharmaceutical Co., Ltd., Shijiazhuang Hebei 050041
  • Online:2026-01-25 Published:2026-03-09

摘要: [目的]探究白头翁皂苷注射液对临床型奶牛乳房炎的治疗效果,为临床型奶牛乳房炎的绿色防控提供新的药物选择与技术支撑。[方法]选取临床型乳房炎奶牛80 头,依据乳房炎病变程度、乳汁性状及体细胞数(SCC)分为4 组,每组20 头。对照组(CON组)采用常规抗生素(头孢噻呋钠)治疗,试验Ⅰ组、试验Ⅱ组、试验Ⅲ组分别肌内注射5、10、15 mL/头的白头翁皂苷注射液(有效成分含量20 mg/mL),连续治疗5 d,停药后观察7 d。[结果]试验Ⅱ组和试验Ⅲ组的治愈率分别达85.0%和80.0%,显著高于CON组的70.0%(P<0.05),试验Ⅰ组治愈率为55.0%,显著低于其他组(P<0.05);治疗后,试验Ⅱ组乳汁体细胞数下降幅度最大,由治疗前的(128.6±15.3)×104 个/mL降至(22.5±3.1)×104 个/mL,显著低于CON组的(35.8±4.2)×104 个/mL(P<0.05);试验Ⅱ组和试验Ⅲ组乳汁中乳酸脱氢酶(LDH)、碱性磷酸酶(AKP)活性显著低于CON组(P<0.05),乳蛋白、乳糖含量显著高于CON组(P<0.05);试验Ⅱ组奶牛血清中白细胞介素-2(IL-2)、肿瘤坏死因子-α(TNF-α)含量显著低于CON组(P<0.05),免疫球蛋白G(IgG)含量显著高于CON组(P<0.05)。[结论]在本试验条件下,10 mL/头剂量的白头翁皂苷注射液对临床型奶牛乳房炎的治疗效果最佳,可有效改善乳汁性状、降低体细胞数、调节机体免疫功能,且无药物残留风险,是临床型奶牛乳房炎防控的理想绿色制剂。

关键词: 白头翁皂苷注射液, 临床型奶牛乳房炎, 治疗效果

Abstract: [Objective] This study aimed to investigate the therapeutic effect of Pulsatilla saponin injection on clinical bovine mastitis,thereby providing new drug options and technical support for its green prevention and control. [Method] Eighty cows with clinical mastitis were selected and divided into four groups of 20 each based on the degree of mastitis lesions,milk traits,and somatic cell count (SCC).The control group (CON)was treated with a conventional antibiotic (ceftiofur sodium). Experimental groups I,II,and III received intramuscular injections of Pulsatilla saponin injection (active ingredient content:20 mg/mL) at doses of 5,10,and 15 mL/cow,respectively,for 5 consecutive days,followed by a 7-day observation period after treatment cessation. [Result] The cure rates in experimental groups II and III were 85.0% and 80.0%,respectively,significantly higher than the 70.0% in the CON group(P<0.05).The cure rate in experimental group I was 55.0%,significantly lower than the other groups(P<0.05).After treatment,the SCC in milk decreased most significantly in experimental group II,from (128.6±15.3)×104 cells/mL before treatment to (22.5±3.1)×104 cells/mL,which was significantly lower than the (35.8±4.2)×104 cells/mL in the CON group (P< 0.05).The activities of lactate dehydrogenase (LDH)and alkaline phosphatase (AKP) in the milk of experimental groups II and III were significantly lower than those in the CON group (P<0.05),while the contents of milk protein and lactose were significantly higher (P<0.05).The serum levels of interleukin-2 (IL-2)and tumor necrosis factor-α (TNF-α) in experimental group II were significantly lower than those in the CON group (P<0.05),whereas the immunoglobulin G (IgG) level was significantly higher (P<0.05). [Conclusion] Under the experimental conditions,Pulsatilla saponin injection at a dose of 10 mL/cow demonstrated the optimal therapeutic effect on clinical bovine mastitis. It effectively improved milk traits,reduced SCC,regulated immune function,and presented a low risk of drug residues,making it an ideal green preparation for the prevention and control of clinical bovine mastitis.

Key words: Pulsatilla saponin injection, clinical bovine mastitis, therapeutic effect

[1] Sharun K,Dhama K,Tiwari R,et al.Advances in therapeutic and managemental approaches of bovine mastitis:A comprehensive review[J]. Veterinary Quarterly,2021,41(1):107-136.
[2] 王晓平,尹立子,王芷涵. 黄腐酚等8种中药单体对奶牛乳房炎临床分离株体外抗菌及抗溶血能力研究[J]. 饲料工业,2025,46(17):102-106.
[3] 李琪瑶,张涵,涂会鑫,等. 抗奶牛乳房炎主要病原菌的乳酸菌细菌素理化特性研究[J]. 家畜生态学报,2024,45(10):66-71.
[4] 赵源,武志勇,于亚明,等. 中药复方对奶山羊隐性乳房炎治疗效果的试验[J]. 畜牧与兽医,2025,57(10):123-130.
[5] 辛桂瑜,曾晓雯,包雨明,等. 白头翁的生物活性及其在动物生产中的应用[J]. 饲料研究,2023,46(12):163-167.
[6] 苏柘僮,肖劲邦,钱柏霖,等. 白头翁皂苷B4对临床型乳房炎奶牛主要临床指标的影响[J]. 中国兽医杂志,2021,57(08):32-37.
[7] 戴建华,姚志兰,张乐,等. 白头翁皂苷B4对临床型乳房炎奶牛生理生化及抗氧化性指标的影响[J]. 扬州大学学报(农业与生命科学版),2022,43(4):51-57.
[8] 张兆兴,石凯,李欣悦,等. 奶牛乳房炎致病菌耐药性及兽用中药治疗研究进展[J]. 中国兽药杂志,2025,59(5):17-23.
[9] 汪培嘉,严静,王银龙,等. 白头翁皂苷注射液对奶牛隐性乳房炎的临床治疗效果[J]. 中国兽医学报,2022,42(10):2064-2070.
[10] 沈留红,钱柏霖,尤留超,等. 白头翁皂苷B4对临床型奶牛乳房炎疗效和血清炎性因子、免疫因子的影响[J]. 浙江农业学报,2021,33(7):1184-1191.
[1] 管鑫, 吕晓静, 崔耀文, 余璐璐, 刘爱玲. 中药复方对奶牛胎衣不下治疗效果与受胎率的影响[J]. 中国乳业, 2025, 0(5): 59-63.
[2] 赵蕾, 李坤林. 中草药散剂对奶牛隐性乳房炎的治疗效果研究[J]. 中国乳业, 2025, 0(4): 66-71.
[3] 李薛强, 张彬, 陈灰. 盲针固定与切口手术对奶牛真胃左方移位治疗效果、经济效益的对比分析[J]. 中国乳业, 2024, 0(10): 50-53.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!